Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990–2019: Estimation based on Global Burden of Disease Study 2019-Reference-Cited by-同舟云学术

Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990–2019: Estimation based on Global Burden of Disease Study 2019

Published:2021-10-24 Issue:1 Volume:40 Page:93-105
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Hu Yuefen¹,Zhang Xiuping²,Zhang Aijun³,Hou Yu¹,Liu Yang¹,Li Qizhao¹,Wang Yawen¹,Yu Yafei¹,Hou Ming¹,Peng Jun¹,Yang Xiaorong⁴^ORCID,Xu Shuqian¹^ORCID

Affiliation:

1. Department of Hematology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong China

2. Medical Experimental Diagnosis Center Jinan Central Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong China

3. Department of Pediatrics Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong China

4. Clinical Epidemiology Unit Qilu Hospital, Shandong University Jinan Shandong China

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2936

Reference37 articles.

1. Leukemia

2. Acute lymphoblastic leukaemia

3. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017

4. Cancer stat facts: Leukemia — acute lymphocytic leukemia (ALL).https://seer.cancer.gov/statfacts/html/alyl.html

5. Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence;Frontiers in Oncology;2024-08-30

2. Comparison of secular trends of leukemia in China and the United States from 1990 to 2021 and their projections for the next 15 years;Frontiers in Public Health;2024-08-16

3. Artificial intelligence reveals the predictions of hematological indexes in children with acute leukemia;BMC Cancer;2024-08-12

4. Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL);Current Treatment Options in Oncology;2024-08-05

5. Acute lymphoblastic leukaemia;Nature Reviews Disease Primers;2024-06-13